ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Psychiatry and Clinical Neurosciences

Psychiatry and Clinical Neurosciences

Volume 56 Issue 3, Pages 255 - 256

Published Online: 6 Jun 2002

Journal compilation © 2010 Japanese Society of Psychiatry and Neurology



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 30K)  | Related Articles | Citation Tracking

Case of head banging that continued to adolescence
YUJI HASHIZUME, md, phdHIDEKAZU YOSHIJIMA, md ,NAOHISA UCHIMURA, md, phd AND HISAO MAEDA, md, phd
  Department of Neuropsychiatry, Kurume University School of Medicine, Kurume, Japan
Correspondence address: Yuji Hashizume, Department of Neuropsychiatry, Kurume University School of Medicine, 67 Asahimachi, Kurume-shi, Fukuoka 830-0011, Japan.
Copyright 2002 Folia Publishing Society
KEYWORDS
adolescence • head banging

ABSTRACT

AbstractHead banging is a rhythmic movement disorder (RMD) along with headrolling and bodyrolling. The average age of onset is 9 months, and by 10 years of age the majority of subjects no longer complain of head banging. A case of head banging in which the symptoms continued to adolescence is reported. The RMD involved the patient abnormally rolling his body or head and hitting his head on walls during sleep. His head bangings were observed during sleep stage 2 and REM sleep. Doses of clonazepam ranging from 0.5 mg to 2 mg were administered for the RMD, which diminished when treated with 2 mg of clonazepam.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1440-1819.2002.00998.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign-up for Content Alerts
Latest News & Information

Sign up for the Neurology NewsWire.

Neuro Newsletter

Get 6 free issues of breaking news and research delivered to your inbox each year!